Division of cancer epidemiology and genetics (dceg) field and biospecimen support services.
Active Awarded Last action
- Contract number
- 75N91022D00006
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 6 $29,599,140 obligated
Award facts
- Opportunity
-
- Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services Pre-Solicitation · 75N91021R00045 · Posted Sep 17, 2021
- Combined order value
-
- $45,396,869 Current, with exercised options
- $96,491,980 Potential, with all options
- Last date to order 87% complete
- IDV ceiling 9% used
- $320,000,000.00
- Maximum order
- $320,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Health and Human Services (HHS) National Cancer Institute (NCI) has awarded Westat, Inc., a for-profit professional services firm, a $320 million multiple-award Indefinite Delivery Contract (IDC) to provide comprehensive field and biospecimen support services for the Division of Cancer Epidemiology and Genetics (DCEG). This 10-year contract, with a period of performance from July 2022 to June 2027, will enable NCI to issue task orders to Westat for a wide range of services, including study management, biospecimen activities, exposure assessment, and clinical support.
Under this IDC, Westat has been awarded several task orders to date, valued at $33.5 million, $5.3 million, $21.5 million, $3.4 million, and $19.8 million, to provide support services for various DCEG research programs and initiatives, such as the Infections and Immunoeidemiology Branch, Integrative Tumor Epidemiology Branch, Agriculture Health Study, and Occupational and Environmental Cancer research. These task orders, which utilize a cost-plus-fixed-fee pricing structure, are focused on delivering epidemiological, clinical, genetic, and exposure assessment support to NCI's extensive portfolio of domestic and international cancer research studies.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N91022D00006?
75N91022D00006 was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on July 1, 2022.
How much is contract 75N91022D00006 worth?
Orders under 75N91022D00006 have obligated $29,599,140. Their combined current value, with exercised options, is $45,396,869. Their combined potential value, with all options, is $96,491,980. 75N91022D00006's own ceiling is $320,000,000. A single order can be worth up to $320,000,000.
How many orders have been placed under contract 75N91022D00006?
6 orders have been placed under 75N91022D00006, the latest on July 1, 2024.
Who can order from contract 75N91022D00006?
75N91022D00006 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N91022D00006 part of a contract vehicle?
Yes. 75N91022D00006 is part of Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services.
Was contract 75N91022D00006 competed?
The extent of competition for 75N91022D00006 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV